Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yaara Ber

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Urologic Oncology|February 16, 2025
Impact of baseline PD-L1 status in BCG naive nonmuscle invasive bladder cancer on outcomes and changes after BCG exposureThomas Gerald, Solomon L Woldu, Daniel Halstuch, et al.
The Journal of Urology|July 14, 2021
Reply by AuthorsKarin Lifshitz, Yaara Ber, Chen Shenhar, et al.
The Journal of Urology|May 25, 2021
Cardiovascular Proteomics: A Post Hoc Analysis from a Phase II Randomized Clinical Trial Comparing GnRH Antagonist vs GnRH Agonist among Men with Advanced Prostate CancerKarin Lifshitz, Yaara Ber, Chen Shenhar, et al.
Carcinogenesis|May 28, 2020
3,3-Diindolylmethane (DIM): a nutritional intervention and its impact on breast density in healthy BRCA carriers. A prospective clinical trialRinat Yerushalmi, Sharon Bargil, Yaara Ber, et al.
Nucleic Acids Research|November 25, 2010
SPIKE: a database of highly curated human signaling pathwaysArnon Paz, Zippora Brownstein, Yaara Ber, et al.
The Journal of Urology|June 13, 2019
Cardiovascular Morbidity in a Randomized Trial Comparing GnRH Agonist and GnRH Antagonist among Patients with Advanced Prostate Cancer and Preexisting Cardiovascular DiseaseDavid Margel, Avivit Peer, Yaara Ber, et al.
The Journal of Urology|September 6, 2019
Reply By AuthorsDavid Margel, Avivit Peer, Yaara Ber, et al.
JACC. Basic to Translational Science|April 1, 2024
Follicle-Stimulating Hormone Exacerbates Cardiovascular Disease in the Presence of Low or Castrate Testosterone LevelsWilhelmina C M Duivenvoorden, David Margel, Vishal Subramony Gayathri, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Urologic Oncology|February 16, 2025
Impact of baseline PD-L1 status in BCG naive nonmuscle invasive bladder cancer on outcomes and changes after BCG exposureThomas Gerald, Solomon L Woldu, Daniel Halstuch, et al.
The Journal of Urology|July 14, 2021
Reply by AuthorsKarin Lifshitz, Yaara Ber, Chen Shenhar, et al.
The Journal of Urology|May 25, 2021
Cardiovascular Proteomics: A Post Hoc Analysis from a Phase II Randomized Clinical Trial Comparing GnRH Antagonist vs GnRH Agonist among Men with Advanced Prostate CancerKarin Lifshitz, Yaara Ber, Chen Shenhar, et al.
Carcinogenesis|May 28, 2020
3,3-Diindolylmethane (DIM): a nutritional intervention and its impact on breast density in healthy BRCA carriers. A prospective clinical trialRinat Yerushalmi, Sharon Bargil, Yaara Ber, et al.
Nucleic Acids Research|November 25, 2010
SPIKE: a database of highly curated human signaling pathwaysArnon Paz, Zippora Brownstein, Yaara Ber, et al.
The Journal of Urology|June 13, 2019
Cardiovascular Morbidity in a Randomized Trial Comparing GnRH Agonist and GnRH Antagonist among Patients with Advanced Prostate Cancer and Preexisting Cardiovascular DiseaseDavid Margel, Avivit Peer, Yaara Ber, et al.
The Journal of Urology|September 6, 2019
Reply By AuthorsDavid Margel, Avivit Peer, Yaara Ber, et al.
JACC. Basic to Translational Science|April 1, 2024
Follicle-Stimulating Hormone Exacerbates Cardiovascular Disease in the Presence of Low or Castrate Testosterone LevelsWilhelmina C M Duivenvoorden, David Margel, Vishal Subramony Gayathri, et al.
Pageof 3